Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT00699179

Femme et Homme

Extrait

This study is conducted in Europe. This observational study is aimed to reflect the post-authorisation experience with insulin analogue (biphasic insulin aspart 30) when used under normal clinical practice conditions in Serbia.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 1 ,Diabetes Mellitus, Type 2

Liens